Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer

被引：0
|
作者：
Kathleen Moore
John K. Chan
Angeles Alvarez Secord
Manish R. Patel
Timothy Callahan
Wei Guo
Zhi-Yi Zhang
机构：
[1] University of Oklahoma HSC,Stephenson Cancer Center
[2] Sarah Cannon Research Institute,Palo Alto Medical Foundation, California Pacific Medical Center
[3] Sutter Health Sutter West Bay,undefined
[4] Duke Cancer Institute,undefined
[5] Florida Cancer Specialists and Research Institute,undefined
[6] BioTel Research,undefined
[7] TESARO,undefined
[8] Inc,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Niraparib; PARP inhibitor; Cardiac repolarization; QTc interval; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：717 / 726
页数：9
相关论文
共 50 条
  • [1] Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Moore, Kathleen
    Chan, John K.
    Secord, Angeles Alvarez
    Patel, Manish R.
    Callahan, Timothy
    Guo, Wei
    Zhang, Zhi-Yi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (04) : 717 - 726
  • [2] Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Kerliu, Lloreta
    Myruski, Samantha
    Bhatti, Afeefa
    Soni, Priyal
    Petrosius, Paulius
    Pervanas, Helen C.
    Horton, Evan R.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (10) : 1010 - 1015
  • [3] Phase 1 and 2 Study of Carboplatin and Pralatrexate in Patients With Recurrent, Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    del Carmen, Marcela G.
    Supko, Jeff G.
    Horick, Nora K.
    Rauh-Hain, J. Alejandro
    Clark, Rachel M.
    Campos, Susana M.
    Krasner, Carolyn N.
    Atkinson, Tina
    Birrer, Michael J.
    CANCER, 2016, 122 (21) : 3297 - 3306
  • [4] A phase II study of chemoimmunotherapy for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube, and primary peritoneal cancers
    Schmeler, K. M.
    Vadhan-Raj, S.
    Ramirez, P. T.
    Cohen, L.
    Garcia, M. E.
    Bassett, R. I.
    Iyer, R. B.
    Mueller, P.
    Levenback, C. L.
    Wolf, J. K.
    Gershenson, D. M.
    Freedman, R. S.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S112 - S112
  • [5] Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
    Mirza, M. R.
    Monk, B. J.
    Herrstedt, J.
    Oza, A. M.
    Mahner, S.
    Redondo, A.
    Fabbro, M.
    Ledermann, J. A.
    Lorusso, D.
    Vergote, I.
    Ben-Baruch, N. E.
    Marth, C.
    Madry, R.
    Christensen, R. D.
    Berek, J. S.
    Dorum, A.
    Tinker, A. V.
    du Bois, A.
    Gonzalez-Martin, A.
    Follana, P.
    Benigno, B.
    Rosenberg, P.
    Gilbert, L.
    Rimel, B. J.
    Buscema, J.
    Balser, J. P.
    Agarwal, S.
    Matulonis, U. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22): : 2154 - 2164
  • [6] Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer
    Matulonis, Ursula
    Berlin, Suzanne
    Lee, Hang
    Whalen, Christin
    Obermayer, Elizabeth
    Penson, Richard
    Liu, Joyce
    Campos, Susana
    Krasner, Carolyn
    Horowitz, Neil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 417 - 423
  • [7] Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer
    Ursula Matulonis
    Suzanne Berlin
    Hang Lee
    Christin Whalen
    Elizabeth Obermayer
    Richard Penson
    Joyce Liu
    Susana Campos
    Carolyn Krasner
    Neil Horowitz
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 417 - 423
  • [8] A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer
    Nakanishi, Toru
    Aoki, Daisuke
    Watanabe, Yoh
    Ando, Yuichi
    Tomotsugu, Naoki
    Sato, Yuji
    Saito, Toshiaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (05) : 422 - 426
  • [9] Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer
    Tomoko Yoshihama
    Yuka Kuroda
    Tatsuyuki Chiyoda
    Mio Takahashi
    Takuma Yoshimura
    Keiko Saotome
    Yoshiko Nanki
    Kensuke Sakai
    Yusuke Kobayashi
    Wataru Yamagami
    Daisuke Aoki
    International Journal of Clinical Oncology, 2022, 27 : 1644 - 1650
  • [10] Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer
    Yoshihama, Tomoko
    Kuroda, Yuka
    Chiyoda, Tatsuyuki
    Takahashi, Mio
    Yoshimura, Takuma
    Saotome, Keiko
    Nanki, Yoshiko
    Sakai, Kensuke
    Kobayashi, Yusuke
    Yamagami, Wataru
    Aoki, Daisuke
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (10) : 1644 - 1650
12345